Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2LHERP in Recurrent Genital Herpes
NCT04235322Phase 4Terminated
- Sponsor
- Labo'Life
- Start
- Jan 2021
- Primary completion
- Apr 2023
- Modality
- Therapeutic Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of 2LHERP in genital herpes, sponsored by Labo'Life. Started Jan 2021; status: terminated.
02
Drugs
2LHERP
03
Conditions
genital herpes
Beyond the preview
Go deeper on NCT04235322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04235322.